179 related articles for article (PubMed ID: 23118370)
1. Current guidelines for total joint VTE prophylaxis: dawn of a new day.
Barrack RL
J Bone Joint Surg Br; 2012 Nov; 94(11 Suppl A):3-7. PubMed ID: 23118370
[TBL] [Abstract][Full Text] [Related]
2. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
Dager WE
Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
[TBL] [Abstract][Full Text] [Related]
3. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.
Stewart DW; Freshour JE
Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty.
Lachiewicz PF
Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism: management by American Association of Hip and Knee Surgeons.
Markel DC; York S; Liston MJ; Flynn JC; Barnes CL; Davis CM;
J Arthroplasty; 2010 Jan; 25(1):3-9.e1-2. PubMed ID: 19837560
[TBL] [Abstract][Full Text] [Related]
6. Succinct review of the new VTE prevention and management guidelines.
Pollak AW; McBane RD
Mayo Clin Proc; 2014 Mar; 89(3):394-408. PubMed ID: 24582197
[TBL] [Abstract][Full Text] [Related]
7. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
[TBL] [Abstract][Full Text] [Related]
8. [The new guidelines for deep venous thromboembolic disease prophylaxis in elective hip and knee replacement surgery. Are we nearer or further away from a consensus?].
Ruiz-Iban MA; Díaz-Heredia J; Elías-Martín ME; Martos-Rodríguez LA; Cebreiro-Martínez del Val I; Pascual-Martín-Gamero FJ
Rev Esp Cir Ortop Traumatol; 2012; 56(4):328-37. PubMed ID: 23594854
[TBL] [Abstract][Full Text] [Related]
9. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
Colwell CW
Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
[TBL] [Abstract][Full Text] [Related]
10. Rationale for thromboprophylaxis in lower joint arthroplasty.
Colwell CW
Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
[TBL] [Abstract][Full Text] [Related]
11. Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty.
Lachiewicz PF
Instr Course Lect; 2011; 60():301-7. PubMed ID: 21553782
[TBL] [Abstract][Full Text] [Related]
12. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?
Eikelboom JW; Karthikeyan G; Fagel N; Hirsh J
Chest; 2009 Feb; 135(2):513-520. PubMed ID: 19201714
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism following primary total hip arthroplasty.
Hitos K; Fletcher JP
Int Angiol; 2009 Jun; 28(3):215-21. PubMed ID: 19506541
[TBL] [Abstract][Full Text] [Related]
14. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
[TBL] [Abstract][Full Text] [Related]
15. Total knee replacement and chemical thromboprophylaxis: current evidence.
Nikolaou VS; Desy NM; Bergeron SG; Antoniou J
Curr Vasc Pharmacol; 2011 Jan; 9(1):33-41. PubMed ID: 21044024
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic disease after total hip and knee arthroplasty.
Haas SB; Barrack RL; Westrich G
Instr Course Lect; 2009; 58():781-93. PubMed ID: 19385586
[TBL] [Abstract][Full Text] [Related]
17. Unanswered questions, unmet needs in venous thromboprophylaxis.
Cushner FD; Nett MP
Orthopedics; 2009 Dec; 32(12 Suppl):62-6. PubMed ID: 20201478
[TBL] [Abstract][Full Text] [Related]
18. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
19. [The attempt of identification of the essentials risk factors of venous thromboembolism after hip arthroplasty despite of pharmacological prophylaxis].
Radziejewicz P; Gregosiewicz A; Bednarek A; Siczek M
Chir Narzadow Ruchu Ortop Pol; 2010; 75(4):242-7. PubMed ID: 21375033
[TBL] [Abstract][Full Text] [Related]
20. DVT prophylaxis in total joint reconstruction.
Sheth NP; Lieberman JR; Della Valle CJ
Orthop Clin North Am; 2010 Apr; 41(2):273-80. PubMed ID: 20399366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
